| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability
|
Adam, Frédéric
|
|
|
20 |
11 |
p. 2666-2678
|
artikel
|
| 2 |
Age‐restricted functional and developmental differences of neonatal platelets
|
Liu, Zhaoyan
|
|
|
20 |
11 |
p. 2632-2645
|
artikel
|
| 3 |
Anti‐GPVI nanobody blocks collagen‐ and atherosclerotic plaque–induced GPVI clustering, signaling, and thrombus formation
|
Jooss, Natalie J.
|
|
|
20 |
11 |
p. 2617-2631
|
artikel
|
| 4 |
Autoinhibitory module underlies species difference in shear activation of von Willebrand factor
|
Arce, Nicholas A.
|
|
|
20 |
11 |
p. 2686-2696
|
artikel
|
| 5 |
Can KCa3.1 channel activators serve as novel inhibitors of platelet aggregation?
|
Wulff, Heike
|
|
|
20 |
11 |
p. 2488-2490
|
artikel
|
| 6 |
Challenges facing early career women in thrombosis and hemostasis—meeting the needs of the next generation
|
Poole, Lauren
|
|
|
20 |
11 |
p. 2453-2455
|
artikel
|
| 7 |
Clot‐targeted magnetic hyperthermia permeabilizes blood clots to make them more susceptible to thrombolysis
|
Cabrera, David
|
|
|
20 |
11 |
p. 2556-2570
|
artikel
|
| 8 |
Early‐onset heparin‐induced thrombocytopenia after cardiac surgery: Should we lose sleep?
|
Pishko, Allyson
|
|
|
20 |
11 |
p. 2491-2493
|
artikel
|
| 9 |
Hereditary angioedema is associated with an increased risk of venous thromboembolism
|
Grover, Steven P.
|
|
|
20 |
11 |
p. 2703-2706
|
artikel
|
| 10 |
Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells
|
Hough, Christine
|
|
|
20 |
11 |
p. 2507-2518
|
artikel
|
| 11 |
HK is the apple of FXI's eye
|
Moellmer, Samantha A.
|
|
|
20 |
11 |
p. 2485-2487
|
artikel
|
| 12 |
"Importance of catecholamine signaling in the development of platelet exhaustion after traumatic injury": Comment
|
Ogweno, Gordon Oluoch
|
|
|
20 |
11 |
p. 2715-2716
|
artikel
|
| 13 |
“Importance of catecholamine signaling in the development of platelet exhaustion after traumatic injury”: Reply
|
Matthay, Zachary A.
|
|
|
20 |
11 |
p. 2717-2718
|
artikel
|
| 14 |
Inhibition of platelet aggregation by activation of platelet intermediate conductance Ca2+‐activated potassium channels
|
Back, Valentina
|
|
|
20 |
11 |
p. 2587-2600
|
artikel
|
| 15 |
Intracellular communication and immunothrombosis in sepsis
|
Iba, Toshiaki
|
|
|
20 |
11 |
p. 2475-2484
|
artikel
|
| 16 |
Issue Information
|
|
|
|
20 |
11 |
p. i-v
|
artikel
|
| 17 |
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
|
Huisman, Menno V.
|
|
|
20 |
11 |
p. 2708-2709
|
artikel
|
| 18 |
“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
|
Schulman, Sam
|
|
|
20 |
11 |
p. 2710-2711
|
artikel
|
| 19 |
ISTH News and Updates: Join the ISTH Today
|
|
|
|
20 |
11 |
p. 2719-2720
|
artikel
|
| 20 |
Minimal role for the alternative pathway in complement activation by HIT immune complexes
|
Barnes, Ayiesha P.
|
|
|
20 |
11 |
p. 2656-2665
|
artikel
|
| 21 |
Most impactful COVID‐19 articles in the field of thrombosis and hemostasis literature
|
Klang, Eyal
|
|
|
20 |
11 |
p. 2700-2702
|
artikel
|
| 22 |
Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen
|
Bar Barroeta, Awital
|
|
|
20 |
11 |
p. 2538-2549
|
artikel
|
| 23 |
Outcomes and management of pregnancy in women with bleeding disorder of unknown cause
|
Castle, Daniel
|
|
|
20 |
11 |
p. 2519-2525
|
artikel
|
| 24 |
Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
|
Lee, Jeffrey
|
|
|
20 |
11 |
p. 2571-2578
|
artikel
|
| 25 |
“Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Comment from Hartmann et al.
|
Hartmann, Jan
|
|
|
20 |
11 |
p. 2711-2712
|
artikel
|
| 26 |
“Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Reply
|
Roberts, Lara N.
|
|
|
20 |
11 |
p. 2713-2714
|
artikel
|
| 27 |
Pulmonary embolism response teams: Changing the paradigm in the care for acute pulmonary embolism
|
Porres‐Aguilar, Mateo
|
|
|
20 |
11 |
p. 2457-2464
|
artikel
|
| 28 |
Quantitative interpretation of PF4/heparin‐EIA optical densities in predicting platelet‐activating VITT antibodies
|
Schönborn, Linda
|
|
|
20 |
11 |
p. 2579-2586
|
artikel
|
| 29 |
Removal of platelets from blood plasma to improve the quality of extracellular vesicle research
|
Bettin, Britta
|
|
|
20 |
11 |
p. 2679-2685
|
artikel
|
| 30 |
Risk of neonatal hypothyroidism in newborns from mothers exposed to CTPA during pregnancy: Ancillary data from a prospective outcome study
|
Righini, Marc
|
|
|
20 |
11 |
p. 2550-2555
|
artikel
|
| 31 |
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study
|
Khider, Lina
|
|
|
20 |
11 |
p. 2697-2699
|
artikel
|
| 32 |
Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study
|
Warkentin, Theodore E.
|
|
|
20 |
11 |
p. 2601-2616
|
artikel
|
| 33 |
The myths behind DOAC measurement: Analyses of prescribing information from different regulatory bodies and a call for harmonization
|
Gosselin, Robert C.
|
|
|
20 |
11 |
p. 2494-2506
|
artikel
|
| 34 |
The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders
|
Degjoni, Anisa
|
|
|
20 |
11 |
p. 2465-2474
|
artikel
|
| 35 |
Time between inhibitor detection and start of immune tolerance induction: Association with outcome in the BrazIT study
|
Camelo, Ricardo Mesquita
|
|
|
20 |
11 |
p. 2526-2537
|
artikel
|
| 36 |
“Vaccine‐induced immune thrombotic thrombocytopenia (VITT)—Update on diagnosis and management considering different resources”: Comment
|
Paez Alacron, Maria Elena
|
|
|
20 |
11 |
p. 2707-2708
|
artikel
|
| 37 |
Variable serotonin release assay pattern and specificity of PF4‐specific antibodies in HIT, and clinical relevance
|
Rollin, Jérôme
|
|
|
20 |
11 |
p. 2646-2655
|
artikel
|
| 38 |
What the neighbors say
|
|
|
|
20 |
11 |
p. 2456
|
artikel
|
Tijdschrift beschrijving